"With the honorary doctorate of the University of Vienna, Emmanuelle Charpentier receives a highly deserved award from the ...

The EU is to set to release a new class of genetically modified crops from strict regulation that dates back over 20 years, ...

Currently, these technologies are subject to the EU’s strict GMO regulation, making their commercialisation in the bloc ...

Casgevy (exagamglogene autotemcel or exa-cel) became the first drug based on the CRISPR/Cas9 gene-editing technology ... which earned its discoverers a Nobel Prize in 2020. The one-shot therapy ...

Human immunodeficiency virus, or HIV, is a virus that attacks the body’s immune system and it can lead to acquired immunodeficiency syndrome (AIDS). Currently, while there is no cure for HIV ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

Casgevy is the first drug to be licensed based on CRISPR, a gene-editing technique for which its discoverers won a Nobel Prize in 2020. It has also been submitted for approval in the US and EU ...

BERLIN: It’s no secret that Donald Trump is obsessed with winning the Nobel Peace Prize, which is one reason why he’s pushing Ukraine and Russia so hard towards ceasefire negotiations.

But it's not just the champions who cash in. Prize money is available at every stage of the competition, meaning that for smaller clubs without the resources of Europe's elite, simply qualifying ...